Primary Cutaneous T-Cell Lymphomas
- 1 January 2006
- journal article
- review article
- Published by American Society of Hematology in Hematology
- Vol. 2006 (1), 323-330
- https://doi.org/10.1182/asheducation-2006.1.323
Abstract
Primary cutaneous T-cell lymphomas (CTCLs) encompass a clinically and biologically heterogeneous group of non-Hodgkin lymphomas (NHLs) defined by clonal proliferation of skin-homing malignant T lymphocytes and natural killer cells. They account for up to 75% to 80% of all cutaneous lymphomas. The current WHO-EORTC classification of cutaneous lymphomas with primary cutaneous manifestations lists 13 entities. The most common subtypes—mycosis fungoides, Sézary syndrome, primary cutaneous anaplastic large cell lymphoma, and lymphomatoid papulosis—which represent approximately 95% of CTCLs, will be discussed in the following review. Each entity has unique biological characteristics and clinical course. Topical and/or systemic therapies are employed based on the stage of the disease and the tempo of progression.Keywords
This publication has 28 references indexed in Scilit:
- EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndromeEuropean Journal of Cancer, 2006
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- Long-term Follow-up of Patients With Early-Stage Cutaneous T-Cell Lymphoma Who Achieved Complete Remission With Psoralen Plus UV-A MonotherapyArchives of Dermatology, 2005
- Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation)International Journal of Radiation Oncology*Biology*Physics, 2004
- Primary cutaneous lymphomas: a review with current treatment optionsBlood Reviews, 2003
- Phase 1 and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell LymphomaArchives of Dermatology, 2002
- Topical Corticosteroids for Mycosis FungoidesArchives of Dermatology, 1998
- Topical carmustine (BCNU) for cutaneous T cell lymphoma: A 15-year experience in 143 patientsJournal of the American Academy of Dermatology, 1990
- Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989
- Recombinant Interferon Alfa-2b in Plaque-Phase Mycosis FungoidesArchives of Dermatology, 1987